Concealment and fabrication by experienced research subjects

Background Subjects who enroll in multiple studies have been found to use deception at times to overcome restrictive screening criteria. Deception undermines subject safety as well as study integrity. Little is known about the extent to which experienced research subjects use deception and what type...

Full description

Saved in:
Bibliographic Details
Published inClinical trials (London, England) Vol. 10; no. 6; pp. 935 - 948
Main Authors Devine, Eric G, Waters, Megan E, Putnam, Megan, Surprise, Caitlin, O’Malley, Katie, Richambault, Courtney, Fishman, Rachel L, Knapp, Clifford M, Patterson, Elissa H, Sarid-Segal, Ofra, Streeter, Chris, Colanari, Laurie, Ciraulo, Domenic A
Format Journal Article
LanguageEnglish
Published London, England SAGE Publications 01.12.2013
Sage Publications Ltd
Subjects
Online AccessGet full text
ISSN1740-7745
1740-7753
1740-7753
DOI10.1177/1740774513492917

Cover

Loading…
Abstract Background Subjects who enroll in multiple studies have been found to use deception at times to overcome restrictive screening criteria. Deception undermines subject safety as well as study integrity. Little is known about the extent to which experienced research subjects use deception and what type of information is concealed, withheld, or distorted. Purpose This study examined the prevalence of deception and types of deception used by subjects enrolling in multiple studies. Methods Self-report of deceptive behavior used to gain entry into clinical trials was measured among a sample of 100 subjects who had participated in at least two studies in the past year. Results Three quarters of subjects reported concealing some health information from researchers in their lifetime to avoid exclusion from enrollment in a study. Health problems were concealed by 32% of the sample, use of prescribed medications by 28%, and recreational drug use by 20% of the sample. One quarter of subjects reported exaggerating symptoms in order to qualify for a study and 14% reported pretending to have a health condition in order to qualify. Limitations Although this study finds high rates of lifetime deceptive behavior, the frequency and context of this behavior is unknown. Understanding the context and frequency of deception will inform the extent to which it jeopardizes study integrity and safety. Conclusion The use of deception threatens both participant safety and the integrity of research findings. Deception may be fueled in part by undue inducements, overly restrictive criteria for entry, and increased demand for healthy controls. Screening measures designed to detect deception among study subjects would aid in both protecting subjects and ensuring the quality of research findings.
AbstractList BACKGROUND: Subjects who enroll in multiple studies have been found to use deception at times to overcome restrictive screening criteria. Deception undermines subject safety as well as study integrity. Little is known about the extent to which experienced research subjects use deception and what type of information is concealed, withheld, or distorted. PURPOSE: This study examined the prevalence of deception and types of deception used by subjects enrolling in multiple studies. METHODS: Self-report of deceptive behavior used to gain entry into clinical trials was measured among a sample of 100 subjects who had participated in at least two studies in the past year. RESULTS: Three quarters of subjects reported concealing some health information from researchers in their lifetime to avoid exclusion from enrollment in a study. Health problems were concealed by 32% of the sample, use of prescribed medications by 28%, and recreational drug use by 20% of the sample. One quarter of subjects reported exaggerating symptoms in order to qualify for a study and 14% reported pretending to have a health condition in order to qualify. LIMITATIONS: Although this study finds high rates of lifetime deceptive behavior, the frequency and context of this behavior is unknown. Understanding the context and frequency of deception will inform the extent to which it jeopardizes study integrity and safety. CONCLUSION: The use of deception threatens both participant safety and the integrity of research findings. Deception may be fueled in part by undue inducements, overly restrictive criteria for entry, and increased demand for healthy controls. Screening measures designed to detect deception among study subjects would aid in both protecting subjects and ensuring the quality of research findings.
Subjects who enroll in multiple studies have been found to use deception at times to overcome restrictive screening criteria. Deception undermines subject safety as well as study integrity. Little is known about the extent to which experienced research subjects use deception and what type of information is concealed, withheld, or distorted. This study examined the prevalence of deception and types of deception used by subjects enrolling in multiple studies. Self-report of deceptive behavior used to gain entry into clinical trials was measured among a sample of 100 subjects who had participated in at least two studies in the past year. Three quarters of subjects reported concealing some health information from researchers in their lifetime to avoid exclusion from enrollment in a study. Health problems were concealed by 32% of the sample, use of prescribed medications by 28%, and recreational drug use by 20% of the sample. One quarter of subjects reported exaggerating symptoms in order to qualify for a study and 14% reported pretending to have a health condition in order to qualify. Although this study finds high rates of lifetime deceptive behavior, the frequency and context of this behavior is unknown. Understanding the context and frequency of deception will inform the extent to which it jeopardizes study integrity and safety. The use of deception threatens both participant safety and the integrity of research findings. Deception may be fueled in part by undue inducements, overly restrictive criteria for entry, and increased demand for healthy controls. Screening measures designed to detect deception among study subjects would aid in both protecting subjects and ensuring the quality of research findings.
Background Subjects who enroll in multiple studies have been found to use deception at times to overcome restrictive screening criteria. Deception undermines subject safety as well as study integrity. Little is known about the extent to which experienced research subjects use deception and what type of information is concealed, withheld, or distorted. Purpose This study examined the prevalence of deception and types of deception used by subjects enrolling in multiple studies. Methods Self-report of deceptive behavior used to gain entry into clinical trials was measured among a sample of 100 subjects who had participated in at least two studies in the past year. Results Three quarters of subjects reported concealing some health information from researchers in their lifetime to avoid exclusion from enrollment in a study. Health problems were concealed by 32% of the sample, use of prescribed medications by 28%, and recreational drug use by 20% of the sample. One quarter of subjects reported exaggerating symptoms in order to qualify for a study and 14% reported pretending to have a health condition in order to qualify. Limitations Although this study finds high rates of lifetime deceptive behavior, the frequency and context of this behavior is unknown. Understanding the context and frequency of deception will inform the extent to which it jeopardizes study integrity and safety. Conclusion The use of deception threatens both participant safety and the integrity of research findings. Deception may be fueled in part by undue inducements, overly restrictive criteria for entry, and increased demand for healthy controls. Screening measures designed to detect deception among study subjects would aid in both protecting subjects and ensuring the quality of research findings.
Subjects who enroll in multiple studies have been found to use deception at times to overcome restrictive screening criteria. Deception undermines subject safety as well as study integrity. Little is known about the extent to which experienced research subjects use deception and what type of information is concealed, withheld, or distorted. This study examined the prevalence of deception and types of deception used by subjects enrolling in multiple studies. Self-report of deceptive behavior used to gain entry into clinical trials was measured among a sample of 100 subjects who had participated in at least two studies in the past year. Three quarters of subjects reported concealing some health information from researchers in their lifetime to avoid exclusion from enrollment in a study. Health problems were concealed by 32% of the sample, use of prescribed medications by 28%, and recreational drug use by 20% of the sample. One quarter of subjects reported exaggerating symptoms in order to qualify for a study and 14% reported pretending to have a health condition in order to qualify. Although this study finds high rates of lifetime deceptive behavior, the frequency and context of this behavior is unknown. Understanding the context and frequency of deception will inform the extent to which it jeopardizes study integrity and safety. The use of deception threatens both participant safety and the integrity of research findings. Deception may be fueled in part by undue inducements, overly restrictive criteria for entry, and increased demand for healthy controls. Screening measures designed to detect deception among study subjects would aid in both protecting subjects and ensuring the quality of research findings. [PUBLICATION ABSTRACT]
Subjects who enroll in multiple studies have been found to use deception at times to overcome restrictive screening criteria. Deception undermines subject safety as well as study integrity. Little is known about the extent to which experienced research subjects use deception and what type of information is concealed, withheld, or distorted.BACKGROUNDSubjects who enroll in multiple studies have been found to use deception at times to overcome restrictive screening criteria. Deception undermines subject safety as well as study integrity. Little is known about the extent to which experienced research subjects use deception and what type of information is concealed, withheld, or distorted.This study examined the prevalence of deception and types of deception used by subjects enrolling in multiple studies.PURPOSEThis study examined the prevalence of deception and types of deception used by subjects enrolling in multiple studies.Self-report of deceptive behavior used to gain entry into clinical trials was measured among a sample of 100 subjects who had participated in at least two studies in the past year.METHODSSelf-report of deceptive behavior used to gain entry into clinical trials was measured among a sample of 100 subjects who had participated in at least two studies in the past year.Three quarters of subjects reported concealing some health information from researchers in their lifetime to avoid exclusion from enrollment in a study. Health problems were concealed by 32% of the sample, use of prescribed medications by 28%, and recreational drug use by 20% of the sample. One quarter of subjects reported exaggerating symptoms in order to qualify for a study and 14% reported pretending to have a health condition in order to qualify.RESULTSThree quarters of subjects reported concealing some health information from researchers in their lifetime to avoid exclusion from enrollment in a study. Health problems were concealed by 32% of the sample, use of prescribed medications by 28%, and recreational drug use by 20% of the sample. One quarter of subjects reported exaggerating symptoms in order to qualify for a study and 14% reported pretending to have a health condition in order to qualify.Although this study finds high rates of lifetime deceptive behavior, the frequency and context of this behavior is unknown. Understanding the context and frequency of deception will inform the extent to which it jeopardizes study integrity and safety.LIMITATIONSAlthough this study finds high rates of lifetime deceptive behavior, the frequency and context of this behavior is unknown. Understanding the context and frequency of deception will inform the extent to which it jeopardizes study integrity and safety.The use of deception threatens both participant safety and the integrity of research findings. Deception may be fueled in part by undue inducements, overly restrictive criteria for entry, and increased demand for healthy controls. Screening measures designed to detect deception among study subjects would aid in both protecting subjects and ensuring the quality of research findings.CONCLUSIONThe use of deception threatens both participant safety and the integrity of research findings. Deception may be fueled in part by undue inducements, overly restrictive criteria for entry, and increased demand for healthy controls. Screening measures designed to detect deception among study subjects would aid in both protecting subjects and ensuring the quality of research findings.
Author Patterson, Elissa H
Ciraulo, Domenic A
Devine, Eric G
Putnam, Megan
Sarid-Segal, Ofra
Fishman, Rachel L
Colanari, Laurie
Waters, Megan E
Richambault, Courtney
Streeter, Chris
O’Malley, Katie
Knapp, Clifford M
Surprise, Caitlin
Author_xml – sequence: 1
  givenname: Eric G
  surname: Devine
  fullname: Devine, Eric G
  email: edevine@bu.edu
– sequence: 2
  givenname: Megan E
  surname: Waters
  fullname: Waters, Megan E
– sequence: 3
  givenname: Megan
  surname: Putnam
  fullname: Putnam, Megan
– sequence: 4
  givenname: Caitlin
  surname: Surprise
  fullname: Surprise, Caitlin
– sequence: 5
  givenname: Katie
  surname: O’Malley
  fullname: O’Malley, Katie
– sequence: 6
  givenname: Courtney
  surname: Richambault
  fullname: Richambault, Courtney
– sequence: 7
  givenname: Rachel L
  surname: Fishman
  fullname: Fishman, Rachel L
– sequence: 8
  givenname: Clifford M
  surname: Knapp
  fullname: Knapp, Clifford M
– sequence: 9
  givenname: Elissa H
  surname: Patterson
  fullname: Patterson, Elissa H
– sequence: 10
  givenname: Ofra
  surname: Sarid-Segal
  fullname: Sarid-Segal, Ofra
– sequence: 11
  givenname: Chris
  surname: Streeter
  fullname: Streeter, Chris
– sequence: 12
  givenname: Laurie
  surname: Colanari
  fullname: Colanari, Laurie
– sequence: 13
  givenname: Domenic A
  surname: Ciraulo
  fullname: Ciraulo, Domenic A
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23867223$$D View this record in MEDLINE/PubMed
BookMark eNqF0UtLAzEQB_AgFfvQuydZ8OJldfLeghcpvqDgRc9LNjvRLfuoyS7Yb-_W1iIF9ZQQfv9hMjMmg7qpkZBTCpeUan1FtQCthaRcTNmU6gMyWj_FWks-2N2FHJJxCAsAlsiEH5Eh44nSjPERuZ41tUVTVli3kanzyJnMF9a0RVNH2SrCjyX6AnuTRx4DGm_fotBlC7RtOCaHzpQBT7bnhLzc3T7PHuL50_3j7GYeWz5N2lhSkNJQJ6ZKUxRUOIUJlcBEooBZtJAb51zuWAYCOOaSMka1yrPMSSkZn5CLTd2lb947DG1aFcFiWZoamy6kVIMEBYrK_6lQTCumQPf0fI8ums7X_UfWikutlYRenW1Vl1WYp0tfVMav0u8R9gA2wPomBI9uRyik6y2l-1vqI2ovYov2a-StN0X5VzDeBIN5xR_t_uY_AeZxnpA
CitedBy_id crossref_primary_10_1177_16094069231224610
crossref_primary_10_1016_S2352_3018_16_30150_3
crossref_primary_10_1080_00952990_2020_1790581
crossref_primary_10_1016_j_cgh_2017_01_026
crossref_primary_10_1002_jcph_689
crossref_primary_10_1016_j_conctc_2016_12_005
crossref_primary_10_1016_j_schres_2019_03_006
crossref_primary_10_1016_j_jpain_2019_12_003
crossref_primary_10_1017_S0963180118000476
crossref_primary_10_1080_00952990_2020_1712723
crossref_primary_10_1097_j_pain_0000000000002204
crossref_primary_10_1136_medethics_2016_103414
crossref_primary_10_24075_medet_2023_006
crossref_primary_10_1016_j_cct_2014_12_004
crossref_primary_10_1177_1740774519877850
crossref_primary_10_1586_17512433_2016_1135734
crossref_primary_10_1016_j_jpsychores_2022_110948
crossref_primary_10_1177_1740774519877851
crossref_primary_10_2196_46523
crossref_primary_10_47924_neurotarget2022124
crossref_primary_10_1007_s11019_022_10092_1
crossref_primary_10_1080_00952990_2019_1689990
crossref_primary_10_1097_PR9_0000000000000854
crossref_primary_10_1016_j_pain_2014_07_015
crossref_primary_10_1016_j_biopsycho_2017_07_019
crossref_primary_10_1080_23294515_2018_1469552
crossref_primary_10_1056_NEJMsb1710591
crossref_primary_10_1001_jamanetworkopen_2018_7355
crossref_primary_10_1080_15284336_2018_1429846
crossref_primary_10_1177_1556264619869538
crossref_primary_10_1111_acer_13213
crossref_primary_10_1016_j_conctc_2021_100713
crossref_primary_10_1016_S2352_3018_19_30233_4
crossref_primary_10_1177_1556264618804962
crossref_primary_10_1002_bimj_201800187
crossref_primary_10_1177_1740774513506619
crossref_primary_10_1093_her_cyae008
crossref_primary_10_1080_10826084_2024_2330892
crossref_primary_10_1080_15265161_2018_1431707
crossref_primary_10_1097_AJP_0000000000000175
crossref_primary_10_1016_j_acra_2021_05_008
crossref_primary_10_1016_j_conctc_2023_101116
crossref_primary_10_1016_j_psychres_2022_114647
crossref_primary_10_1016_j_addicn_2023_100090
crossref_primary_10_1080_14461242_2023_2261433
crossref_primary_10_1111_acer_14611
crossref_primary_10_1097_QAI_0000000000001818
crossref_primary_10_1080_15265161_2018_1431703
crossref_primary_10_1177_1948550617698203
crossref_primary_10_1016_j_cct_2018_08_002
crossref_primary_10_1097_JCP_0000000000000372
crossref_primary_10_1111_acer_15062
crossref_primary_10_1186_s12910_022_00783_y
crossref_primary_10_1016_j_addbeh_2024_107996
crossref_primary_10_1016_j_copsyc_2019_01_009
crossref_primary_10_1056_NEJMp1506985
crossref_primary_10_1177_1556264614568280
crossref_primary_10_1002_jcph_2135
crossref_primary_10_1111_opn_12572
crossref_primary_10_1016_j_clinthera_2017_08_009
crossref_primary_10_1097_MPG_0000000000002904
crossref_primary_10_1371_journal_pone_0245460
crossref_primary_10_1080_10508422_2018_1535976
crossref_primary_10_4103_JQSH_JQSH_23_18
crossref_primary_10_1177_2168479018770644
crossref_primary_10_1097_j_pain_0000000000001849
crossref_primary_10_1002_eahr_404002
crossref_primary_10_1016_j_eclinm_2019_10_007
crossref_primary_10_1093_ntr_ntaa105
crossref_primary_10_1111_acer_13556
crossref_primary_10_2196_66384
crossref_primary_10_1016_j_josat_2023_209011
crossref_primary_10_1093_ntr_ntab077
crossref_primary_10_1177_1556264618820219
crossref_primary_10_1093_ntr_nty033
crossref_primary_10_1177_1477750917749954
crossref_primary_10_1016_j_psym_2017_05_001
Cites_doi 10.2307/3564136
10.1001/jama.2011.354
10.1176/ajp.147.5.682-a
10.1353/pbm.2003.0094
10.1215/9780822393245
10.1007/s002280050364
10.1136/jme.2002.001594
10.1038/440388a
10.1038/clpt.1994.161
10.1172/JCI25694
10.1046/j.1360-0443.2001.969131911.x
10.1097/CCM.0b013e3181921c9d
10.1016/S0009-9236(96)90063-6
ContentType Journal Article
Copyright The Author(s), 2013
SAGE Publications © Dec 2013
Copyright_xml – notice: The Author(s), 2013
– notice: SAGE Publications © Dec 2013
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7RV
7TK
7TS
7U7
7X7
7XB
88E
8C1
8FI
8FJ
8FK
8G5
ABUWG
AFKRA
AN0
AZQEC
BENPR
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
GUQSH
K9.
KB0
M0S
M1P
M2O
MBDVC
NAPCQ
PADUT
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
7T2
DOI 10.1177/1740774513492917
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Proquest Nursing & Allied Health Source
Neurosciences Abstracts
Physical Education Index
Toxicology Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
British Nursing Database
ProQuest Central Essentials
ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One
ProQuest Central Korea
ProQuest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Research Library
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Medical Database ProQuest
Research Library
Research Library (Corporate)
Nursing & Allied Health Premium
Research Library China
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
Health and Safety Science Abstracts (Full archive)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Research Library (Alumni Edition)
ProQuest Central China
Physical Education Index
Environmental Sciences and Pollution Management
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Research Library
ProQuest Central (New)
Research Library China
ProQuest Medical Library (Alumni)
ProQuest Public Health
ProQuest Central Basic
Toxicology Abstracts
ProQuest One Academic Eastern Edition
British Nursing Index with Full Text
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
Health & Safety Science Abstracts
DatabaseTitleList Health & Safety Science Abstracts
MEDLINE

Research Library Prep
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1740-7753
EndPage 948
ExternalDocumentID 3143646341
23867223
10_1177_1740774513492917
10.1177_1740774513492917
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAAA NIH HHS
  grantid: R01 AA015923
GroupedDBID ---
-TM
.2E
.2J
.2N
01A
04C
0R~
1~K
29B
31R
31U
31X
31Z
36B
4.4
53G
54M
5GY
5RE
5VS
6PF
7RV
7X7
88E
8C1
8FI
8FJ
8G5
8R4
8R5
AABMB
AACMV
AACTG
AADUE
AAEWN
AAGLT
AAGMC
AAJPV
AAKGS
AAQDB
AAQXI
AARDL
AARIX
AATAA
AATBZ
AAUAS
AAWTL
ABAWP
ABCCA
ABCJG
ABEIX
ABFWQ
ABHQH
ABIDT
ABJIS
ABJZC
ABKRH
ABLUO
ABPNF
ABQXT
ABRHV
ABTDE
ABUJY
ABUWG
ABVFX
ACARO
ACDSZ
ACDXX
ACFEJ
ACGFS
ACGZU
ACJER
ACJTF
ACLFY
ACLZU
ACOFE
ACOXC
ACPRK
ACROE
ACRPL
ACSIQ
ACUAV
ACUIR
ACXKE
ACXMB
ADBBV
ADDLC
ADEBD
ADNMO
ADNON
ADRRZ
ADVBO
ADYCS
ADZZY
AECGH
AEDTQ
AEIJN
AEKYL
AENEX
AEPTA
AEQLS
AERKM
AESZF
AEUHG
AEWDL
AEWHI
AEXNY
AFEET
AFKRA
AFKRG
AFMOU
AFQAA
AFRAH
AFUIA
AFWMB
AGHKR
AGKLV
AGNHF
AGPXR
AGQPQ
AGWFA
AGWNL
AHDMH
AHHFK
AHMBA
AIIQI
AJUZI
AJXAJ
ALIPV
ALKWR
ALMA_UNASSIGNED_HOLDINGS
AMCVQ
AN0
ANDLU
ARTOV
ASPBG
AUTPY
AUVAJ
AVWKF
AYAKG
AZFZN
AZQEC
B3H
B8M
B8R
B8Z
B94
BBRGL
BDDNI
BENPR
BKEYQ
BKIIM
BKSCU
BMSDO
BNQBC
BPACV
BPHCQ
BSEHC
BVXVI
BWJAD
CAG
CCPQU
CDWPY
CFDXU
COF
CS3
DB0
DC-
DC.
DF0
DO-
DOPDO
DU5
DV7
DV9
DWQXO
EBD
EBS
EIHBH
EJD
EMB
EMOBN
EX3
F5P
FEDTE
FHBDP
FYUFA
GNUQQ
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
GUQSH
H13
HF~
HMCUK
HVGLF
HZ~
J8X
K.F
M1P
M2O
N9A
NAPCQ
O9-
P.B
P2P
PADUT
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
Q2X
Q7L
Q7U
Q83
ROL
S01
SASJQ
SAUOL
SCNPE
SDB
SFC
SFK
SFT
SGO
SGR
SGV
SGZ
SHG
SNB
SPJ
SPQ
SPV
STM
SV3
UDS
UKHRP
WOW
YHZ
ZGI
ZONMY
ZPPRI
ZRKOI
ZSSAH
AAYXX
AJGYC
CITATION
3V.
AADTT
ACSBE
ACTQU
AEUIJ
AIOMO
ALTZF
CGR
CUY
CVF
ECM
EIF
M4V
NPM
7TK
7TS
7U7
7XB
8FK
AAPII
AJVBE
C1K
K9.
MBDVC
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
Q9U
7X8
7T2
ID FETCH-LOGICAL-c398t-51055a1f49671e414f6e8150248602cec0dafffdf2b0403ed5122176dbbf55523
IEDL.DBID 7X7
ISSN 1740-7745
1740-7753
IngestDate Thu Jul 10 22:59:40 EDT 2025
Thu Jul 10 18:50:38 EDT 2025
Sat Jul 26 02:16:23 EDT 2025
Wed Feb 19 02:32:28 EST 2025
Tue Jul 01 02:44:51 EDT 2025
Thu Apr 24 23:11:07 EDT 2025
Tue Jun 17 22:28:24 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c398t-51055a1f49671e414f6e8150248602cec0dafffdf2b0403ed5122176dbbf55523
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
PMID 23867223
PQID 1463577650
PQPubID 40366
PageCount 14
ParticipantIDs proquest_miscellaneous_1705060615
proquest_miscellaneous_1462762607
proquest_journals_1463577650
pubmed_primary_23867223
crossref_primary_10_1177_1740774513492917
crossref_citationtrail_10_1177_1740774513492917
sage_journals_10_1177_1740774513492917
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-12-01
PublicationDateYYYYMMDD 2013-12-01
PublicationDate_xml – month: 12
  year: 2013
  text: 2013-12-01
  day: 01
PublicationDecade 2010
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: England
– name: London
PublicationTitle Clinical trials (London, England)
PublicationTitleAlternate Clin Trials
PublicationYear 2013
Publisher SAGE Publications
Sage Publications Ltd
Publisher_xml – name: SAGE Publications
– name: Sage Publications Ltd
References Bentley, Thacker 2004; 30
Waldman 2006; 440
Risch, Lewine, Jewart 1990; 147
Randolph 2009; 37
Apseloff, Swayne, Gerber 1996; 60
Resnik, Koski 2011; 305
Fry, Dwyer 2001; 96
Hermann, Heger-Mahn, Mahler 1997; 53
Grady 2005; 115
Apseloff, Ashton, Friedman 1994; 56
Tishler, Bartholomae 2003; 46
Boyar, Goldfarb 2010; 6
Macklin 1981; 3
bibr1-1740774513492917
bibr3-1740774513492917
bibr14-1740774513492917
bibr8-1740774513492917
bibr12-1740774513492917
Boyar D (bibr6-1740774513492917) 2010; 6
bibr10-1740774513492917
bibr2-1740774513492917
bibr11-1740774513492917
bibr9-1740774513492917
bibr5-1740774513492917
bibr13-1740774513492917
bibr7-1740774513492917
bibr4-1740774513492917
29621441 - Am J Bioeth. 2018 Apr;18(4):87-88
26398069 - N Engl J Med. 2015 Sep 24;373(13):1192-3
24287132 - Clin Trials. 2013;10(6):840-1
References_xml – volume: 3
  start-page: 1
  year: 1981
  end-page: 6
  article-title: On paying money to research subjects: ‘due’ and ‘undue’ inducements
  publication-title: IRB
– volume: 46
  start-page: 508
  year: 2003
  end-page: 20
  article-title: Repeat participation among normal healthy research volunteers: Professional guinea pigs in clinical trials?
  publication-title: Perspect Biol Med
– volume: 37
  start-page: S107
  year: 2009
  end-page: 11
  article-title: The unique challenges of enrolling patients into multiple clinical trials
  publication-title: Crit Care Med
– volume: 53
  start-page: 207
  year: 1997
  end-page: 14
  article-title: Adverse events and discomfort in studies on healthy subjects: The volunteer’s perspective
  publication-title: Eur J Clin Pharmacol
– volume: 60
  start-page: 353
  year: 1996
  end-page: 56
  article-title: Medical histories may be unreliable in screening volunteers for clinical trials
  publication-title: Clin Pharmacol Ther
– volume: 147
  start-page: 682
  year: 1990
  end-page: 83
  article-title: Ensuring the normalcy of ‘normal’ volunteers
  publication-title: Am J Psychiatry
– volume: 96
  start-page: 1319
  year: 2001
  end-page: 25
  article-title: For love or money? An exploratory study of why injecting drug users participate in research
  publication-title: Addiction
– volume: 440
  start-page: 388
  year: 2006
  end-page: 89
  article-title: London’s disastrous drug trial has serious side effects for research
  publication-title: Nature
– volume: 30
  start-page: 293
  year: 2004
  end-page: 98
  article-title: The influence of risk and monetary payment on the research participation decision making process
  publication-title: J Med Ethics
– volume: 56
  start-page: 460
  year: 1994
  end-page: 62
  article-title: The importance of measuring cotinine levels to identify smokers in clinical trials
  publication-title: Clin Pharmacol Ther
– volume: 305
  start-page: 1236
  year: 2011
  end-page: 37
  article-title: A national registry for healthy volunteers in phase 1 clinical trials
  publication-title: JAMA
– volume: 115
  start-page: 1681
  year: 2005
  end-page: 87
  article-title: Payment of clinical research subjects
  publication-title: J Clin Invest
– volume: 6
  start-page: 1
  year: 2010
  end-page: 4
  article-title: Preventing overlapping enrollment in clinical studies
  publication-title: J Clin Res Best Pract
– ident: bibr8-1740774513492917
  doi: 10.2307/3564136
– ident: bibr13-1740774513492917
  doi: 10.1001/jama.2011.354
– ident: bibr10-1740774513492917
  doi: 10.1176/ajp.147.5.682-a
– ident: bibr5-1740774513492917
  doi: 10.1353/pbm.2003.0094
– ident: bibr3-1740774513492917
  doi: 10.1215/9780822393245
– ident: bibr12-1740774513492917
  doi: 10.1007/s002280050364
– ident: bibr9-1740774513492917
  doi: 10.1136/jme.2002.001594
– ident: bibr1-1740774513492917
  doi: 10.1038/440388a
– ident: bibr11-1740774513492917
  doi: 10.1038/clpt.1994.161
– ident: bibr14-1740774513492917
  doi: 10.1172/JCI25694
– ident: bibr2-1740774513492917
  doi: 10.1046/j.1360-0443.2001.969131911.x
– ident: bibr4-1740774513492917
  doi: 10.1097/CCM.0b013e3181921c9d
– volume: 6
  start-page: 1
  year: 2010
  ident: bibr6-1740774513492917
  publication-title: J Clin Res Best Pract
– ident: bibr7-1740774513492917
  doi: 10.1016/S0009-9236(96)90063-6
– reference: 29621441 - Am J Bioeth. 2018 Apr;18(4):87-88
– reference: 24287132 - Clin Trials. 2013;10(6):840-1
– reference: 26398069 - N Engl J Med. 2015 Sep 24;373(13):1192-3
SSID ssj0028583
Score 2.306218
Snippet Background Subjects who enroll in multiple studies have been found to use deception at times to overcome restrictive screening criteria. Deception undermines...
Subjects who enroll in multiple studies have been found to use deception at times to overcome restrictive screening criteria. Deception undermines subject...
BACKGROUND: Subjects who enroll in multiple studies have been found to use deception at times to overcome restrictive screening criteria. Deception undermines...
SourceID proquest
pubmed
crossref
sage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 935
SubjectTerms Bioethics
Clinical trials
Clinical Trials as Topic
Deception
Female
Human subjects
Humans
Income
Male
Middle Aged
Motivation
Patient Selection
Research Subjects
Self Report
Sex Factors
Unemployment
Title Concealment and fabrication by experienced research subjects
URI https://journals.sagepub.com/doi/full/10.1177/1740774513492917
https://www.ncbi.nlm.nih.gov/pubmed/23867223
https://www.proquest.com/docview/1463577650
https://www.proquest.com/docview/1462762607
https://www.proquest.com/docview/1705060615
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZS8NAEB7Ugvgi3saLCCL4EJrNtQkIosVShIqIQt_Knvggqdr2wX_vzHbbemBfkrDZkGVnN_PNkW8AzhTqvKrSVVSlWkSZKvGKCx0xrWMlWSpSl4zZvS86z9ldL-95h9vQp1VOv4nuQ60HinzkTdzRac45Aoqrt_eIqkZRdNWX0FiGBlGXkfHFe3ODq8wdDSeC7hhRZJbPw5RNaqMmx85XuXJl39TSH6z5I8_LqZ72Bqx7zBheT4S8CUum3oLVro-Kb8Nli_49pEIo9SgUtQ6tkB_eFxfKz9DM6Ix16Ml9XsLhWJILZrgDz-3bp1Yn8lURIpVW5SgiRJQLZrOq4MxkLLOFKRHWJa6clDIq1sJaq20icYOmRqNKR7uj0FLaPEe7cxdW6kFt9iGUrLAqzTMjpUI70pSx0kwnnOEpEWkRQHM6KX3lKcOpcsVrn3mW8N_TGMDF7Im3CV3Ggr5H03nu-40z7M_FHMDp7DYueYpjiNoMxq5PwskQ4wv68JioExGvBbA3keFsQIhSCo6wKIBzEuq3l_8z0oPFIz2EtYSKZLgklyNYGX2MzTFClZE8cesRj2WLnUDj5vb-4fELWkjhbg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VRQIuqOXV0AJGAiQO0cZ2EicSqEIL1ZZ2e2ql3oKf4oCypbsr1D_Fb2TGm6QFxN56SpQ4ijWe8Xz2jL8BeG3R59W1q9NaOp3mtsI7pV3Kncus4VLLmIw5PSknZ_mX8-J8A371Z2EorbKfE-NE7WaW9shHaNGyUAoBxf7Fj5SqRlF0tS-hsVKLI3_1E5ds8w-Hn3B83whx8Pl0PEm7qgKplXW1SAlRFJqHvC4V9znPQ-krhEUilmOy3mZOhxBcEAYVXHqHLhFxe-mMCUVRENEBTvl3cikVcfVX4yGlRFRFpP1EkJ8has2L67DoiJ7Ro8gGWMfyaDfc4D_Y9o-8sujqDrbgQYdR2ceVUm3Dhm8fwt1pF4V_BO_HdNaRCq-0C6Zbx4I2l93eHzNXzA_0yY51ZELf2HxpaMtn_hjObkVeT2CznbV-B5jhZbCyyL0xFtetvsqs404ojhehZZnAqBdKYzuKcqqU8b3hHSv532JM4N3wxcWKnmNN271ezk1nqPPmWq0SeDW8RhOjuIlu_WwZ2whFCz-1po3KiKoR8WECT1djOHQIUVGpEIYl8JYG9cbP_9PTZ-t7-hLuTU6nx83x4cnRLtwXVKAjJtjswebicumfI0xamBdRNxl8vW1j-A12chqp
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Concealment+and+fabrication+by+experienced+research+subjects&rft.jtitle=Clinical+trials+%28London%2C+England%29&rft.au=Devine%2C+Eric+G&rft.au=Waters%2C+Megan+E&rft.au=Putnam%2C+Megan&rft.au=Surprise%2C+Caitlin&rft.date=2013-12-01&rft.issn=1740-7745&rft.eissn=1740-7753&rft.volume=10&rft.issue=6&rft.spage=935&rft.epage=948&rft_id=info:doi/10.1177%2F1740774513492917&rft.externalDBID=n%2Fa&rft.externalDocID=10_1177_1740774513492917
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1740-7745&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1740-7745&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1740-7745&client=summon